Arkolith/Insider Trading/HRMY/Form 4

Dayno Jeffrey M.

PRESIDENT, CEO, DirectorHarmony Biosciences Holdings, Inc. (HRMY) · full profile →Form 4 · filed Dec 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2025Sell(S)6K$40.11$238K0
Dec 12, 2025Sell(S)20K$40.11$802K0
Dec 12, 2025Option exercise(M)20K$8.22$164K20K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2025Option exercise(M)20K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001615993-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML